Gene · 5976
Papers2,361
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,361
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human UPF3A and UPF3B enable fault-tolerant activation of nonsense-mediated mRNA decay. | EMBO J | 2022 | 35451084 | PubTator, text mining | PubMed |
| Tumor suppressor BAP1 nuclear import is governed by transportin-1. | J Cell Biol | 2022 | 35446349 | PubTator, text mining | PubMed |
| The biological behavior of tRNA-derived fragment tRF-Leu-AAG in pancreatic cancer cells. | Bioengineered | 2022 | 35442152 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| Quantitative and kinetic single-molecule analysis of DNA unwinding by Escherichia coli UvrD helicase. | Biophys Physicobiol | 2022 | 35435650 | PubTator, text mining | PubMed |
| Measuring the impact of cofactors on RNA helicase activities. | Methods | 2022 | 35429628 | PubTator, text mining | PubMed |
| Proteome-wide quantitative RNA-interactome capture identifies phosphorylation sites with regulatory potential in RBM20. | Mol Cell | 2022 | 35427468 | PubTator, text mining | PubMed |
| Translational Control of COVID-19 and Its Therapeutic Implication. | Front Immunol | 2022 | 35422818 | PubTator, text mining | PubMed |
| SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer. | Cell Death Discov | 2022 | 35422067 | PubTator, text mining | PubMed |
| A developmentally programmed splicing failure contributes to DNA damage response attenuation during mammalian zygotic genome activation. | Sci Adv | 2022 | 35417229 | PubTator, text mining | PubMed |
| Comprehensive analysis of ZFPM2-AS1 prognostic value, immune microenvironment, drug sensitivity, and co-expression network: from gastric adenocarcinoma to pan-cancers. | Discov Oncol | 2022 | 35416526 | PubTator, text mining | PubMed |
| Replication of the coronavirus genome: A paradox among positive-strand RNA viruses. | J Biol Chem | 2022 | 35413290 | PubTator, text mining | PubMed |
| The Physiological Roles of the Exon Junction Complex in Development and Diseases. | Cells | 2022 | 35406756 | PubTator, text mining | PubMed |
| A Quality Control Mechanism of Splice Site Selection Abrogated under Stress and in Cancer. | Cancers (Basel) | 2022 | 35406522 | PubTator, text mining | PubMed |
| An alternative UPF1 isoform drives conditional remodeling of nonsense-mediated mRNA decay. | EMBO J | 2022 | 35403729 | PubTator, text mining | PubMed |
| Modulation of RNA stability regulates gene expression in two opposite ways: through buffering of RNA levels upon global perturbations and by supporting adapted differential expression. | Nucleic Acids Res | 2022 | 35390159 | PubTator, text mining | PubMed |
| SIX5-activated LINC01468 promotes lung adenocarcinoma progression by recruiting SERBP1 to regulate SERPINE1 mRNA stability and recruiting USP5 to facilitate PAI1 protein deubiquitylation. | Cell Death Dis | 2022 | 35387981 | PubTator, text mining | PubMed |
| ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function. | Cell Rep | 2022 | 35385738 | PubTator, text mining | PubMed |
| Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus. | Nat Neurosci | 2022 | 35379995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5976/papers?page=28